SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-014663
Filing Date
2021-06-17
Accepted
2021-06-17 16:31:18
Documents
15
Period of Report
2021-06-17
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 62516
2 ex3-1.htm EX-3.1 2276
3 ex3-1_001.jpg GRAPHIC 69385
4 ex3-1_002.jpg GRAPHIC 153293
  Complete submission text file 0001493152-21-014663.txt   550278

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE crbp-20210617.xsd EX-101.SCH 3035
6 XBRL LABEL FILE crbp-20210617_lab.xml EX-101.LAB 34914
7 XBRL PRESENTATION FILE crbp-20210617_pre.xml EX-101.PRE 22795
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3786
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37348 | Film No.: 211025150
SIC: 2834 Pharmaceutical Preparations